A Collaborative Study to Evaluate the Efficacy of Prospective Post-Induction Infliximab Dosing Based on Trough Levels at week 12 and 28 in Subjects with Crohn's Disease (CD) and Ulcerative Colitis (UC)
Latest Information Update: 27 Oct 2016
At a glance
- Drugs Infliximab (Primary)
- Indications Crohn's disease; Irritable bowel syndrome; Ulcerative colitis
- Focus Therapeutic Use
- 27 Oct 2016 New trial record